KRSNAA — Krsnaa Diagnostics Share Price
Last trade - 00:00- IN₹24.27bn
- IN₹25.18bn
- IN₹6.20bn
- 63
- 16
- 62
- 45
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 21.31 | ||
| PEG Ratio (f) | 0.67 | ||
| EPS Growth (f) | 46.53% | ||
| Dividend Yield (f) | 1.78% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.94 | ||
| Price to Tang. Book | 2.95 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 3.54 | ||
| EV to EBITDA | 14.16 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 10.55% | ||
| Return on Equity | 9.48% | ||
| Operating Margin | 13.82% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 2,584.27 | 3,964.56 | 4,554.5 | 4,871.23 | 6,196.33 | 7,767.5 | 9,732.5 | 24.25% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | -61.1 | -16.13 | -10.01 | +41.45 | +46.53 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Krsnaa Diagnostics Limited is an India-based company primarily engaged in the business of providing diagnostic services primarily in relation to pathology investigation, radiology investigation and tele reporting. The Company’s service offerings cover pathology, X-Ray, and computed tomography (CT) scan, magnetic resonance imaging (MRI), USG, tele-radiology, tele-pathology, and other diagnostic services. Its laboratory services span a diverse range of investigations, ranging from routine to highly specialized tests. Its teleradiology services enable radiologists to offer treatment remotely. Teleradiology involves transmitting radiological images, such as CT scans, digitized X-rays, MRIs and ultrasounds between different locations. It offers various health packages in addition to its Ayaksham package. It provides diagnostic testing packages for diabetes, heart health, liver health, kidney health, thyroid, fatigue, cancer, senior citizen care, bone health, infection screening, and more.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 22nd, 2010
- Public Since
- August 16th, 2021
- No. of Shareholders
- 56,458
- No. of Employees
- 3,700
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 32,289,763
- Address
- S.No.243,A-Hissa No.6/6 CTS No.4519, Pune, 411 019
- Web
- https://krsnaadiagnostics.com/
- Phone
- +91 2027350025
- Auditors
- MSKA & Associates
Upcoming Events for KRSNAA
Similar to KRSNAA
Aatmaj Healthcare
National Stock Exchange of India
Apollo Hospitals Enterprise
National Stock Exchange of India
Artemis Medicare Services
National Stock Exchange of India
Aster DM Healthcare
National Stock Exchange of India
Chandan Healthcare
National Stock Exchange of India
FAQ
As of Today at 21:39 UTC, shares in Krsnaa Diagnostics are trading at IN₹765.15. This share price information is delayed by 15 minutes.
Shares in Krsnaa Diagnostics last closed at IN₹765.15 and the price had moved by +33.86% over the past 365 days. In terms of relative price strength the Krsnaa Diagnostics share price has outperformed the S&P BSE 100 Index by +26.1% over the past year.
The overall consensus recommendation for Krsnaa Diagnostics is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Krsnaa Diagnostics dividend yield is 0.33% based on the trailing twelve month period.
Last year, Krsnaa Diagnostics paid a total dividend of IN₹2.50, and it currently has a trailing dividend yield of 0.33%. We do not have any data on when Krsnaa Diagnostics is to next pay dividends.
We do not have data on when Krsnaa Diagnostics is to next pay dividends. The historic dividend yield on Krsnaa Diagnostics shares is currently 0.33%.
To buy shares in Krsnaa Diagnostics you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹765.15, shares in Krsnaa Diagnostics had a market capitalisation of IN₹24.27bn.
Here are the trading details for Krsnaa Diagnostics:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: KRSNAA
Based on an overall assessment of its quality, value and momentum Krsnaa Diagnostics is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Krsnaa Diagnostics is IN₹1,050.54. That is 37.3% above the last closing price of IN₹765.15.
Analysts covering Krsnaa Diagnostics currently have a consensus Earnings Per Share (EPS) forecast of IN₹24.50 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Krsnaa Diagnostics. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -0.35%.
As of the last closing price of IN₹765.15, shares in Krsnaa Diagnostics were trading -5.51% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Krsnaa Diagnostics PE ratio based on its reported earnings over the past 12 months is 21.31. The shares last closed at IN₹765.15.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Krsnaa Diagnostics' directors